Positive results from trial of SNG001 in COVID-19 patients
Synairgen announces positive results from trial of SNG001 in hospitalised COVID-19 patients Patients who received SNG001 had a 79% lower risk of developing severe disease...
The Pharmacy & Drugs category covers the safe, effective and evidence-based use of medications and therapies. It explores how medicines work, current prescribing practices, regulatory developments and issues affecting access, safety and innovation. From insights on drug interactions and adherence to analysis of emerging treatments, this category supports informed decision-making for clinicians, pharmacists and healthcare consumers alike.